如何看待干扰素α在晚期肾细胞癌治疗中的作用
被引量：1
摘要
从20世纪80年代起，干扰素α（IFN-α）和白细胞介素-2（IL-2）一直被用作转移性肾癌的一线治疗药物。我国由于尚无高剂量的IL-2产品，IFN-α成为治疗转移性肾癌的主要药物。近年来针对血管内皮生长因子（VEGF）及受体的多靶点激酶抑制剂治疗转移性肾癌取得了较好的临床疗效，不良反应明显低于细胞因子。中华医学会泌尿外科学分会（CUA）制定的《肾细胞癌诊断治疗指南》推荐对转移性肾癌的治疗以化疗、细胞因子治疗和靶向治疗为主。
出处
《中华泌尿外科杂志》
CAS
CSCD
北大核心
2009年第1期7-9,共3页
Chinese Journal of Urology
参考文献8
-
1Coppin C, Porzsolt F, Awa A, et al. Immunotherapy for advanced renal cell cancer. Cochrane Database Syst Rev, 2005, 25 : 1425.
-
2Motzer RJ, Baeik J, Murphy BA, et al. Interferonalfa as a comparative treatment for clinical trials of new therapiesagainst advanced renal cell carcinoma. J Clin Oncol, 2002, 20: 289-296.
-
3Negrier S, Perol D, Ravaud A, et al. Do cytokines improve survival in patients with metastatic renal cell carcinoma (MRCC) of intermediate prognosis? Results of the prospective randomized PERCY Quattro trial. J Clin Oncol, 2005, 23 (Suppl) : 380.
-
4Flanigan RC, Blumenstein BA, Salmon SE. Cytoreduction nephrectomy in metastatic renal cancer: the results of Southwest Oncology Group Trial 8949. J Clin Oncol, 2000, 18(Suppl): 3.
-
5Mickisch GHJ, Garin A, van Poopel H, et al. Radical nephrectomy plus interferon alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma., a randomized trial. Lancet, 2001, 358: 966-970.
-
6Bromwich E, McMillan DC, Lamb GW, et al. The systemic inflammatory response, performance status and survival in patients undergoing alpha-interferon treatment for advanced renal cancer. Br J Cancer, 2004, 91 : 1236-1238.
-
7Bracarda S, Porta C, Boni C, et al. Randomized prospective phase Ⅱ trial of two schedules of sorafenib daily and interfer-on-α2a (IFN) in metastatic renal cell carcinoma (RAPSODY) : GOIRC Study 0681. J Clin Oncol, 2007, 25(Suppl) : 259.
-
8Escudier B, Koralewski P, Pluzanska A, et al. A randomized, controlled, double-blind phase Ⅲ study (AVOREN) of bevacizumab/interferon-α2a vs placebo/interferon- α2a as first-line therapy in metastatic renal cell carcinoma. J Clin Oncol, 2007, 25(Suppl) : 2.
同被引文献14
-
1Park JW,Jo MK,Lee HM.Significance of 18F-fluorodeoxyglucose positron-emission tomography/computed tomography for the postoperative surveillance of advanced renal cell carcinoma[J].BJU Int,2009,103:615-619.
-
2Nativ O,Sabo E,Reiss A,et al.Clinical significance of tumor angiogenesis in patients with localized renal cell carcinoma[J].Urology,1998,51:693-696.
-
3Bechtold RE,Dyer RB,Zagoria R J,et al.The perirenal space:relationship of pathologic processes to normal retroperitoneal anatomy[J].Radiographics,1996,16:841-854.
-
4Karellas ME,Jang TL,Kagiwada MA,et al.Advanced-stage renal cell carcinoma treated by radical nephrectomy and adjacent organ or structure resection[J].BJU Int,2009,13:160-164.
-
5Margulis V,Sanchez-Ortiz RF,Tamboli P,et al.Renal cell carcinoma clinically involving adjacent organs:experience with aggressive surgical management[J].Cancer,2007,109:2025-2030.
-
6Guethmundsson E,Hellborg H,Lundstam S,et al.Metastatic potential in renal cell carcinomas </=7 cm:Swedish Kidney Cancer Quality Register data[J].Eur Urol,2011,60:975-982.
-
7Abel EJ,Culp SH,Meissner M,et al.Identifying the risk of disease progression after surgery for localized renal cell carcinoma[J].BJU Int,2010,106:1277-1283.
-
8Ares VY.Correlation between symptoms and survival in patients with renal cell carcinoma[J].Arch Esp Urol,2009,62:201-206.
-
9Skinner DG,Colvin RB,Vermillion CD,et al.Diagnosis and management of renal cell carcinoma.a clinical and pathologic study of 309 cases[J].Cancer,1971,28:1165-1177.
-
10Flanigan RC,Mickisch G,Sylvester R,et al.Cytoreductive nephrectomy in patients with metastatic renal cancer:a combined analysis[J].J Urol,2004,171:1071-1076.
引证文献1
-
1寿建忠,马建辉,郑玮,肖振东,肖泽均,田军,王栋,毕新刚,管考鹏,李长岭.单纯侵犯腹膜的T4期肾癌临床分析[J].中华泌尿外科杂志,2014,35(3):165-167. 被引量：1
-
1杨俊兰.细胞因子治疗实体瘤的现状[J].解放军医学情报,1994,8(4):178-179.
-
2黄俊祥.转移性肾癌的诊治进展[J].大家健康（学术版）,2013(3):68-69. 被引量：1
-
3高德宗,孙靖中.Fas系统与肿瘤治疗[J].国外医学（肿瘤学分册）,2005,32(5):368-371. 被引量：7
-
4彭俊杰,蔡三军.大肠癌的生物治疗进展[J].标记免疫分析与临床,2005,12(1):46-49.
-
5王薇.头颈肿瘤细胞因子治疗现状与展望[J].国外医学（耳鼻咽喉科学分册）,2000,24(1):20-23. 被引量：2
-
6肖正达,金冠球,谢宇野,林向阳,徐瑾.内镜下注细胞因子治疗晚期胃癌[J].中华消化内镜杂志,1997,14(1):38-39.
-
7王德斌.癌生物治疗进展[J].高科技与产业化,2000,6(3):15-19.
-
8郑航,李长建,李军,靳全恒,窦启锋.后腹腔镜下肾部分切除术联合过继免疫疗法应用于肾癌的疗效分析[J].湖南师范大学学报（医学版）,2016,13(4):95-97. 被引量：4
-
9杨华,王华庆.肾透明细胞癌的全身治疗现状及进展[J].国外医学（外科学分册）,2005,32(6):449-453.
-
10傅友军,马鹏程.细胞因子治疗黑素瘤的进展[J].国际皮肤性病学杂志,2006,32(5):282-284.
